Citurgia Biochemicals reports standalone net loss of Rs 0.11 crore in the December 2023 quarter - Business Standard
KREBSBIO | 78.88 0.98 1.26% |
Under 52% of Krebs Biochemicals' investor base is interested to short. The analysis of overall sentiment of trading Krebs Biochemicals and stock suggests that many investors are impartial at this time. Krebs Biochemicals' investing sentiment shows overall attitude of investors towards Krebs Biochemicals and.
Krebs |
Citurgia Biochemicals reports standalone net loss of Rs 0.11 crore in the December 2023 quarter Business Standard
Read at news.google.com
![]() |
Krebs Biochemicals Fundamental Analysis
We analyze Krebs Biochemicals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Krebs Biochemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Krebs Biochemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Krebs Biochemicals is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Krebs Biochemicals and Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Krebs Biochemicals stock to make a market-neutral strategy. Peer analysis of Krebs Biochemicals could also be used in its relative valuation, which is a method of valuing Krebs Biochemicals by comparing valuation metrics with similar companies.
Peers
Krebs Biochemicals Related Equities
RATNAMANI | Ratnamani Metals | 2.26 | ||||
SHYAMMETL | Shyam Metalics | 0.16 | ||||
LFIC | Lakshmi Finance | 0.97 | ||||
PAYTM | One 97 | 1.46 | ||||
KAVVERITEL | Kavveri Telecom | 2.00 | ||||
RIIL | Reliance Industrial | 4.23 | ||||
TNTELE | Tamilnadu Telecommunicatio | 5.07 | ||||
UNIINFO | Uniinfo Telecom | 8.26 |
Complementary Tools for Krebs Stock analysis
When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |